Welcome to our dedicated page for Sequans Communications S A SEC filings (Ticker: SQNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sequans Communications S.A. uses Form 6-K reports to document its foreign-private-issuer disclosures for a France-based issuer whose American depositary shares represent ordinary shares. The filings include unaudited financial results, press-release exhibits, incorporation by reference into Form S-8 and Form F-3 registration statements, and disclosures tied to its 4G/5G cellular IoT semiconductor business.
Recent filings also cover shareholder meeting materials under French corporate law, ADS voting and ordinary-share capital actions, board and management changes, NYSE continued-listing compliance, secured convertible debenture arrangements, and Bitcoin digital-asset treasury matters. These records frame Sequans’ governance, capital structure, registration capacity, and public-company reporting obligations.
Schedule 13D/A Amendment No. 4 highlights a decline in the ownership percentage of Sequans Communications (SQNS) by 272 Capital LP and its president Wes Cummins.
- Current stake (as of 7 July 2025): Cummins beneficially owns 40,251,840 ordinary shares (4,025,184 ADSs), while 272 Capital owns 39,329,840 ordinary shares (3,932,984 ADSs). Both stakes equal 2.8 % of Sequans’ outstanding shares.
- Loss of 5 % reporting status: The reporting persons confirm they have ceased to be 5 % beneficial owners as of 7 July 2025, triggering this amendment.
- Share-count dynamics: The percentage drop is driven largely by a surge in Sequans’ share count to 1,427,163,962 ordinary shares (142,714,545 ADSs) versus 247.8 million a year earlier. Termination/sale of managed funds also removed roughly 5.7 million shares from the group across 2024-25.
- Warrant grants: Cummins receives recurring board-service compensation. The filing notes a new June 2025 warrant grant for 360,000 shares (36,000 ADSs) that vests through June 2026; earlier grants from 2018-2024 have fully vested.
- Voting & dispositive power: Cummins holds sole power over 922,000 shares via exercisable warrants and shares power with 272 Capital over the remaining 39.33 million shares.
No transactions were executed in the 60-day period preceding each reference date other than the warrant grant. Overall, the amendment primarily formalises the group’s drop below the 5 % threshold rather than signaling active buying or selling.
Sequans Communications S.A. (NYSE: SQNS) has received a NYSE notice of non-compliance with Section 802.01B covering minimum global market capitalization and shareholders’ equity. Over the past 30 consecutive trading days the company’s average market cap fell below US$50 million and its stockholders’ equity is also under US$50 million, triggering the deficiency.
The notification does not cause immediate delisting. Sequans must, within 90 days (by 7 September 2025), submit a detailed business plan demonstrating how it will regain compliance within a 9-month cure period. The NYSE will respond to the plan within 45 days of receipt. During this period, the American Depositary Shares will continue to trade under ticker “SQNS” but will carry the suffix “.BC” to indicate “below compliance”.
Failure to meet the plan milestones or restore market capitalization/equity levels within the specified timeframe could result in suspension and delisting. Management states that it is “evaluating available options” and intends to cure the deficiency; no specific actions or financial measures were disclosed in the filing.
Sequans Communications S.A. (NYSE: SQNS) has received a NYSE notice of non-compliance with Section 802.01B covering minimum global market capitalization and shareholders’ equity. Over the past 30 consecutive trading days the company’s average market cap fell below US$50 million and its stockholders’ equity is also under US$50 million, triggering the deficiency.
The notification does not cause immediate delisting. Sequans must, within 90 days (by 7 September 2025), submit a detailed business plan demonstrating how it will regain compliance within a 9-month cure period. The NYSE will respond to the plan within 45 days of receipt. During this period, the American Depositary Shares will continue to trade under ticker “SQNS” but will carry the suffix “.BC” to indicate “below compliance”.
Failure to meet the plan milestones or restore market capitalization/equity levels within the specified timeframe could result in suspension and delisting. Management states that it is “evaluating available options” and intends to cure the deficiency; no specific actions or financial measures were disclosed in the filing.